Annabel Samimy
Stock Analyst at Stifel
(3.33)
# 913
Out of 4,842 analysts
56
Total ratings
39.58%
Success rate
25.36%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Annabel Samimy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LGND Ligand Pharmaceuticals | Initiates: Buy | $143 | $100.00 | +43.00% | 1 | Apr 10, 2025 | |
| PVLA Palvella Therapeutics | Initiates: Buy | $45 | $23.83 | +88.84% | 1 | Mar 26, 2025 | |
| GPCR Structure Therapeutics | Initiates: Buy | $50 | $22.20 | +125.23% | 1 | Jan 8, 2025 | |
| ALT Altimmune | Initiates: Buy | $18 | $5.49 | +227.87% | 1 | Jan 8, 2025 | |
| IVA Inventiva | Maintains: Buy | $20 → $17 | $3.40 | +400.00% | 4 | Nov 22, 2024 | |
| MBX MBX Biosciences | Initiates: Buy | $40 | $12.59 | +217.71% | 1 | Oct 8, 2024 | |
| KMDA Kamada | Initiates: Buy | $18 | $6.89 | +161.25% | 1 | Jul 3, 2024 | |
| PHAT Phathom Pharmaceuticals | Initiates: Buy | $24 | $4.08 | +488.24% | 1 | May 3, 2024 | |
| RGNX REGENXBIO | Maintains: Buy | $40 | $8.54 | +368.38% | 2 | Apr 12, 2024 | |
| VKTX Viking Therapeutics | Reiterates: Buy | $80 | $27.13 | +194.88% | 6 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $230 | $107.01 | +114.93% | 8 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 → $25 | $9.30 | +168.82% | 1 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $19.66 | +78.07% | 1 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $65 | $16.80 | +286.90% | 3 | Aug 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $28 → $11 | $0.32 | +3,359.12% | 4 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $15.84 | +184.09% | 1 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $8 | $0.79 | +917.04% | 1 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $0.62 | +3,767.85% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $20 | $29.54 | -32.30% | 1 | Apr 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $700 → $750 | $1.45 | +51,624.14% | 3 | Apr 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $25 → $24 | $32.19 | -25.44% | 7 | Apr 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $15 → $21 | $0.52 | +3,946.24% | 6 | Sep 18, 2019 |
Ligand Pharmaceuticals
Apr 10, 2025
Initiates: Buy
Price Target: $143
Current: $100.00
Upside: +43.00%
Palvella Therapeutics
Mar 26, 2025
Initiates: Buy
Price Target: $45
Current: $23.83
Upside: +88.84%
Structure Therapeutics
Jan 8, 2025
Initiates: Buy
Price Target: $50
Current: $22.20
Upside: +125.23%
Altimmune
Jan 8, 2025
Initiates: Buy
Price Target: $18
Current: $5.49
Upside: +227.87%
Inventiva
Nov 22, 2024
Maintains: Buy
Price Target: $20 → $17
Current: $3.40
Upside: +400.00%
MBX Biosciences
Oct 8, 2024
Initiates: Buy
Price Target: $40
Current: $12.59
Upside: +217.71%
Kamada
Jul 3, 2024
Initiates: Buy
Price Target: $18
Current: $6.89
Upside: +161.25%
Phathom Pharmaceuticals
May 3, 2024
Initiates: Buy
Price Target: $24
Current: $4.08
Upside: +488.24%
REGENXBIO
Apr 12, 2024
Maintains: Buy
Price Target: $40
Current: $8.54
Upside: +368.38%
Viking Therapeutics
Mar 15, 2024
Reiterates: Buy
Price Target: $80
Current: $27.13
Upside: +194.88%
Mar 15, 2024
Maintains: Buy
Price Target: $225 → $230
Current: $107.01
Upside: +114.93%
Mar 8, 2024
Reiterates: Buy
Price Target: $23 → $25
Current: $9.30
Upside: +168.82%
Oct 5, 2023
Initiates: Buy
Price Target: $35
Current: $19.66
Upside: +78.07%
Aug 29, 2023
Maintains: Buy
Price Target: $60 → $65
Current: $16.80
Upside: +286.90%
Jun 26, 2023
Downgrades: Hold
Price Target: $28 → $11
Current: $0.32
Upside: +3,359.12%
Mar 7, 2023
Initiates: Buy
Price Target: $45
Current: $15.84
Upside: +184.09%
Nov 10, 2022
Upgrades: Buy
Price Target: $8
Current: $0.79
Upside: +917.04%
Aug 24, 2021
Initiates: Buy
Price Target: $24
Current: $0.62
Upside: +3,767.85%
Apr 24, 2020
Initiates: Hold
Price Target: $20
Current: $29.54
Upside: -32.30%
Apr 16, 2020
Maintains: Buy
Price Target: $700 → $750
Current: $1.45
Upside: +51,624.14%
Apr 16, 2020
Maintains: Hold
Price Target: $25 → $24
Current: $32.19
Upside: -25.44%
Sep 18, 2019
Maintains: Hold
Price Target: $15 → $21
Current: $0.52
Upside: +3,946.24%